References
- Jacobs V, Cutler MJ, Day JD, et al. Atrial fibrillation and dementia. Trends Cardiovasc Med. 2015;25:44–51.
- Wolf PA, Dawber TR, Thomas HE Jr., et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study. Neurology. 1978;28:973–977.
- Andersen LV, Vestergaard P, Deichgraeber P, et al. Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis. Heart. 2008;94:1607–1613.
- Santhanakrishnan R, Wang N, Larson MG, et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133:484–492.
- Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952.
- Olsen J. Register-based research: some methodological considerations. Scand J Public Health. 2011;39:225–229.
- Kennedy HL. Silent atrial fibrillation: definition, clarification, and unanswered issues. Ann Noninvasive Electrocardiol. 2015;20:518–525.
- Available at: http://ec.europa.eu/justice/data-protection/reform/index_en.htm. 2016.